Primary prevention in rheumatology:: the importance of hyperuricemia

被引:66
作者
Vázquez-Mellado, J
Hernández, EA
Burgos-Vargas, R
机构
[1] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Rheumatol Serv, Mexico City 06726, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Div Res, Mexico City 04510, DF, Mexico
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2004年 / 18卷 / 02期
关键词
hyperuricemia; gout; uric acid; cardiovascular diseases; renal diseases; metabolic syndrome;
D O I
10.1016/j.berh.2004.01.001
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Hyperuricemia (HU) is present in 5-30% of the general population, although the prevalence is higher among some ethnic groups and seems to be increasing worldwide. Classically, chronic HU has been considered a risk factor for gout or lithiasis and is associated with alcoholism, obesity, hypertension, dyslipidemia, hyperglicemia/diabetes mellitus, renal failure and intake of certain drugs. HU is also associated with cardiovascular diseases such as hypertension, vascular disease, pre-eclampsia, pulmonary arterial hypertension, stroke, heart failure, ischemic heart disease and also metabolic syndrome, renal disease and increased mortality. It is uncertain if these associations are dependent or not, especially cardiovascular and renal diseases. Patients with chronic HU and also those with gout require both medical investigation for associated diseases or drugs as well as nutritional counseling and life-style changes. HU should alert physicians to possible complications.
引用
收藏
页码:111 / 124
页数:14
相关论文
共 106 条
[1]
ADAM O, 1998, EUROPEAN J MED RES, V21, P77
[2]
Serum uric acid and cardiovascular events in successfully treated hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S ;
Kivlighn, S .
HYPERTENSION, 1999, 34 (01) :144-150
[3]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[4]
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[5]
[Anonymous], 2001, GUID DOC US IN VITR
[6]
BANDO K, 1988, J THORAC CARDIOV SUR, V95, P465
[7]
Fenofibrate and losartan [J].
Bardin, T .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (06) :497-498
[8]
REQUIEM FOR GOUTY NEPHROPATHY [J].
BECK, LH ;
HARRINGTON, JT ;
KASSIRER, JP ;
PERRONE, R ;
MADIAS, NE ;
STROM, J ;
KURTIN, P ;
CANZANELLO, V .
KIDNEY INTERNATIONAL, 1986, 30 (02) :280-287
[9]
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension [J].
Bendayan, D ;
Shitrit, D ;
Ygla, M ;
Huerta, M ;
Fink, G ;
Kramer, MR .
RESPIRATORY MEDICINE, 2003, 97 (02) :130-133
[10]
RENAL-FUNCTION IN GOUT .4. ANALYSIS OF 524 GOUTY SUBJECTS INCLUDING LONG-TERM FOLLOW-UP STUDIES [J].
BERGER, L ;
YU, TF .
AMERICAN JOURNAL OF MEDICINE, 1975, 59 (05) :605-613